lead position
Sponsored content
Sponsored by
GlobalBlock
Features list
-
A review of 11 cases shows that pharmaceutical patents in Russia are being upheld despite having been invalidated in Europe. Yana Lipatova says companies should carefully review the grounds in each case
-
In-house counsel tell Simon Crompton how their IP outsourcing to India has grown, to encompass everything from docketing to patent drafting. And a survey of the top providers compares their services
-
David Ehrlich reveals some lesser-known uses of US trade marks that could keep foreign trade mark owners from having their US rights wiped out
-
Last year’s European Patent Office rule changes are playing out better in practice than many feared. Richard Howson cautiously predicts that the office is becoming more user-friendly
-
Edward Kelly and Franck Fougère debate the merits of Thailand’s programme of compulsory licensing for pharmaceutical patents.
-
The Court of Justice of the EU has become increasingly important to patent law in Europe. Businesses need to be aware how this will shape European patents in the future, say Katie Hutchinson, Simon Llewellyn, Rachel Mumby and Steven Willis
Local Insights